Insider Trading25 Jun 2026, 11:04 am
Vista Pharma Closes Trading Window for Q2 2026 Results
AI Summary
Vista Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The trading window will be closed from July 1, 2026, and will reopen 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. All designated persons and their immediate relatives are prohibited from trading in the company's shares during this period. The date of the board meeting to consider these financial results will be communicated later.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for unaudited financial results of Q2 2026.
- Reopening after 48 hours of results declaration.
- Applies to designated persons and immediate relatives.
- Compliance with SEBI (Prohibition of Insider Trading) Regulations.
Price Impact
More from VISTAPH